FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to therapy and neurology, and concerns alleviating the symptoms associated with such cranial nerves as trigeminal, facial, glossopharyngeal or vagal. For this purpose, a pharmaceutical composition containing an analgesic and an anesthetic is introduced into the external auditory canal.
EFFECT: it provides reduction of painful sensations after tonzillotomy and adenoidectomy, relief of asthma attacks, neurogenic cough and other symptoms due to local auricular anesthesia and blocking of transfer of afferent and efferent signals transferred through the specified nerves.
8 cl, 7 dwg, 9 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING AURICULAR PAIN BY ANESTHESIA OF CRANIAL NERVES | 2016 |
|
RU2701548C1 |
| METHOD OF SNORE TREATMENT | 2009 |
|
RU2410133C1 |
| METHOD OF BODY EXPOSURE | 2012 |
|
RU2502528C1 |
| THERAPY OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY | 2005 |
|
RU2380094C2 |
| DEVICE FOR TRANSCUTANEOUS NERVE STIMULATION OF HUMAN BODY | 2006 |
|
RU2393884C2 |
| METHOD FOR IMPROVING THE HEALTH OF A PATIENT USING OSTEOPATHIC TECHNIQUES ON THE EXTRACRANIAL ENDINGS OF THE MENINGEAL AFFERENTS OF THE CRANIAL NERVES | 2021 |
|
RU2794636C1 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
| DIBENZO-AZEPINE COMPOUNDS AND USE THEREOF FOR TREATING EAR DISEASES AND DISORDERS | 2016 |
|
RU2707284C1 |
| CYSTATHIONINE-γ-LYASE (CSE) INHIBITORS | 2013 |
|
RU2661879C2 |
| METHOD OF TREATING PATIENTS WITH DEAFNESS | 2008 |
|
RU2393838C1 |
